Single Patient IND: Continued Administration of G-202 to a Patient With Advanced Hepatocellular Carcinoma Previously Treated With G-202 and Receiving Clinical Benefit
Latest Information Update: 14 Apr 2014
At a glance
- Drugs Mipsagargin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Inspyr Therapeutics
- 14 Apr 2014 New trial record